Literature DB >> 19178066

Choosing topical corticosteroids.

Jonathan D Ference1, Allen R Last.   

Abstract

Topical corticosteroids are one of the oldest and most useful treatments for dermatologic conditions. There are many topical steroids available, and they differ in potency and formulation. Successful treatment depends on an accurate diagnosis and consideration of the steroid's delivery vehicle, potency, frequency of application, duration of treatment, and side effects. Although use of topical steroids is common, evidence of effectiveness exists only for select conditions, such as psoriasis, vitiligo, eczema, atopic dermatitis, phimosis, acute radiation dermatitis, and lichen sclerosus. Evidence is limited for use in melasma, chronic idiopathic urticaria, and alopecia areata.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19178066

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  42 in total

1.  Pathways to managing atopic dermatitis: consensus from the experts.

Authors:  Mark G Lebwohl; James Q Del Rosso; William Abramovits; Brian Berman; David E Cohen; Emma Guttman; Anthony J Mancini; Lawrence A Schachner
Journal:  J Clin Aesthet Dermatol       Date:  2013-07

2.  Use of topical glucocorticoids in veterinary dermatology.

Authors:  Frédéric Sauvé
Journal:  Can Vet J       Date:  2019-07       Impact factor: 1.008

3.  A Point Prevalence Study of Antimicrobial Use and Practice Among Nursing Homes in Singapore.

Authors:  Aysu Selcuk; Kai Zhen Yap; Chee Liang Wong; Jing Xi Yang; Pei Chean Yong; Sui Yung Chan; Christine B Teng
Journal:  Drugs Aging       Date:  2019-06       Impact factor: 3.923

4.  Generalized Concentration Addition Model Predicts Glucocorticoid Activity Bioassay Responses to Environmentally Detected Receptor-Ligand Mixtures.

Authors:  Elizabeth Medlock Kakaley; Mary C Cardon; L Earl Gray; Phillip C Hartig; Vickie S Wilson
Journal:  Toxicol Sci       Date:  2019-03-01       Impact factor: 4.849

5.  A clinical drug library screen identifies clobetasol propionate as an NRF2 inhibitor with potential therapeutic efficacy in KEAP1 mutant lung cancer.

Authors:  E-J Choi; B-J Jung; S-H Lee; H-S Yoo; E-A Shin; H-J Ko; S Chang; S-Y Kim; S-M Jeon
Journal:  Oncogene       Date:  2017-05-15       Impact factor: 9.867

6.  Pharmacology: potency rankings.

Authors:  M Carrozzo
Journal:  Br Dent J       Date:  2014-08       Impact factor: 1.626

Review 7.  The use of topical steroid preparations in oral medicine in the UK.

Authors:  M Rudralingam; C Randall; A J Mighell
Journal:  Br Dent J       Date:  2017-11-03       Impact factor: 1.626

Review 8.  Child with atopic dermatitis.

Authors:  Watcharoot Kanchongkittiphon; Jonathan M Gaffin; Wanda Phipatanakul
Journal:  Ann Allergy Asthma Immunol       Date:  2015-01       Impact factor: 6.347

9.  Effect of Topical Application of the Cream Containing Magnesium 2% on Treatment of Diaper Dermatitis and Diaper Rash in Children A Clinical Trial Study.

Authors:  Seyyed Mohammad-Kazem Nourbakhsh; Hojjatollah Rouhi-Boroujeni; Maryam Kheiri; Mahmoud Mobasheri; Majid Shirani; Saeedeh Ahrani; Javad Karami; Zahra Keivani Hafshejani
Journal:  J Clin Diagn Res       Date:  2016-01-01

10.  Effect of topical steroid (0.05% clobetasol propionate) treatment in children with severe phimosis.

Authors:  Chan Ho Lee; Sang Don Lee
Journal:  Korean J Urol       Date:  2013-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.